Quote:
|
Originally Posted by ziggy Hey bro I appreciate your evidence for DNP however I was a little concerned by the spec sheet for the antibody for DNP as an antidote. Antibodies aren't antidotes; they do however have an integral part in the adaptive immune response. This is done by immature B-cells in the bone marrow being selected for affinity for an antigen. Once selection has taken place the B-cell becomes a plasma cell secreting antibodies specific for the antigen. The way the antibody can kill/remove the antigen is to be recognized by a T-helper cell which is MHC-restricted. Then programmed death (apotosis) can occur. The antibody on the spec sheet is made from a host other than human which means that if you introduced this Ig into a human the host will recognize this as foreign and build an immune response to it. Also if the foreign Ig is able to bind DNP in the host it would not allow program cell death because the T-helper cell has to be MHC restricted meaning that it will not recognize anitigen that is in the binding pocket of the major histocompatibility complex. That's all I have to say about that but I would like to try some DNP, maybe pm me so that I can get some, Thanks |
Wow....someone likes to use their science book to write.

I'll try and keep my explanation down a little closer to those of us that read plain old English.
Why does DNP work, it basically causes the KATP gateway to stay open, allowing a inefficiency in the formation of ATP (energy packets) and the need for the body to use more fat to produce the same amount of energy. The Antidote (ne: antibody), is actually a proteolytic (sorry...big word) that allows the KATP gateway to be shut....thereby causing DNP to have less effect.
I like your thoughts Ziggy, but in this case the agent acts a little different than through the binding of antibody to the DNP molecule. Cellular death in this case does not result from a suppression of the immune system (re: T-Cell activity). The antibody is not designed to help the immune system, so therefore there is no need for it to be MHC restricted, and at the required doseage and time frame the half-life is such that the immune system should not immediately respond in a fashion which would reduce it's effectiveness.
Bottom line: Keep with the required doses and the last two posts become totally irrelevant unless you are an ER doc who is about to $h!t his pants because he has an idiot laying on a table in a pool of sweat.
As far as "giving it a try", please don't until you read much more research about the drug and the action that it has on a cellular level.
Hope this helps,
Kemo